Abrdn PLC Codexis, Inc. Transaction History
Abrdn PLC
- $61.6 Billion
- Q3 2025
A detailed history of Abrdn PLC transactions in Codexis, Inc. stock. As of the latest transaction made, Abrdn PLC holds 4,092,062 shares of CDXS stock, worth $6.75 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
4,092,062
Previous 4,200,950
2.59%
Holding current value
$6.75 Million
Previous $10.3 Million
2.6%
% of portfolio
0.02%
Previous 0.02%
Shares
7 transactions
Others Institutions Holding CDXS
# of Institutions
144Shares Held
68.3MCall Options Held
42KPut Options Held
31.8K-
Opaleye Management Inc. Boston, MA12.8MShares$21.1 Million5.2% of portfolio
-
Black Rock Inc. New York, NY6.79MShares$11.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.67MShares$7.71 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny4.07MShares$6.71 Million0.0% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT4.03MShares$6.65 Million0.4% of portfolio
About CODEXIS, INC.
- Ticker CDXS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 65,494,100
- Market Cap $108M
- Description
- Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protei...